Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
ACRV holding history
Acrivon Therapeutics, Inc. in every 13F filed by Perceptive Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACRV overviewAll 13F holders of ACRVFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −5,360,858−100.0% | Sold out | Holders |
| Q1 2025 | 5,360,858 | $10.9M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2024 | 5,360,858 | $32.3M | 0.9% | 00.0% | Unchanged | Holders |
| Q3 2024 | 5,360,858 | $37.5M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2024 | 5,360,858 | $31.1M | 0.8% | +2,353,000+78.2% | Added | Holders |
| Q1 2024 | 3,007,858 | $21.5M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,007,858 | $14.8M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,007,858 | $28.8M | 1.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,007,858 | $39.0M | 1.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,007,858 | $38.2M | 1.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,007,858 | $34.7M | 1.0% | +3,007,858 | New | Holders |